RSSL Webinar: Nitrosamines Analysis

Hosted by RSSL's Daniel Nicolau, this webinar considers the challenges of method development for nitrosamine analysis and the risk nitrosamines can pose

Hosted by RSSL's Daniel Nicolau, this webinar considers the challenges of method development for nitrosamine analysis and the risk nitrosamines can pose.


Nitrosamines Analysis - Better Understanding the Risk

Analysing a pharma product for all possible nitrosamines can involve a long process of method development and validation, particularly in complex matrices with low analytical thresholds. But are there better methods available?

By targeting the most likely occurring nitrosamines for a product by utilising unique chemistry and formulation, may better describe the risk and reduce the complexity and time of laboratory analysis.


In this webinar we discuss:

  • The challenges of method development for nitrosamines in pharmaceutical products
  • Focused description of the risk nitrosamines poses in a specific product
  • Generating the right analytical data to better describe the risk


To view this webinar on demand please click here.




ABOUT THE PRESENTER

Dr Daniel Nicolau - RSSL Technical Expert

Joining RSSL in 2013, Daniel has taken a leading role in the delivery of RSSL’s quantitative and investigative LC-MS techniques and our new Nitrosamines testing service. Recognised as a technical specialist in key analytical fields, Daniel’s chemical knowledge, resourcefulness and expertise across a wide range of instrument types enables him to assist clients with their regulatory submissions and troubleshooting needs.





Related Services

how biologics have changed the pharma industry

Make an Enquiry